PARAMUS, N.J.–(BUSINESS WIRE) July 20, 2021 –The U.S. Food and Drug Administration (FDA) has granted…
View More FDA Approves Octapharma’s Octagam 10% for Adult Dermatomyositis
Home »
FDA Approves Kerendia
FDA Approves Kerendia (finerenone) for the Treatment of Patients with Chronic Kidney Disease Associated with…
View More FDA Approves Kerendia
FDA Approves Camcevi
FDA Approves Camcevi (leuprolide mesylate) for the Treatment of Advanced Prostate Cancer TAIPEI, May 26,…
View More FDA Approves Camcevi
FDA approves higher-dose naloxone hydrochloride nasal spray
(HealthDay)—The U.S. Food and Drug Administration approved use of a higher dose of naloxone hydrochloride…
View More FDA approves higher-dose naloxone hydrochloride nasal spray
FDA Approves Nextstellis
FDA Approves Nextstellis (drospirenone and estetrol) Oral Contraceptive for Birth Control 15 April 2021, Adelaide,…
View More FDA Approves Nextstellis
FDA Approves Qelbree
FDA Approves Qelbree (viloxazine) for the Treatment of ADHD ROCKVILLE, Md., April 02, 2021 (GLOBE NEWSWIRE) — Supernus…
View More FDA Approves Qelbree
FDA OKs Neuromodulation Device to Improve Gait in MS
The US Food and Drug Administration (FDA) has approved the Portable Neuromodulation Stimulator (PoNS, Helius…
View More FDA OKs Neuromodulation Device to Improve Gait in MS
FDA review reveals J&J COVID-19 vaccine safe, effective
A single-shot COVID-19 vaccine made by Johnson & Johnson completely prevented hospitalizations and deaths in…
View More FDA review reveals J&J COVID-19 vaccine safe, effective
FDA Approves Breyanzi
FDA Approves Breyanzi (lisocabtagene maraleucel) CAR-T Cell Therapy for Adults with Relapsed or Refractory Large…
View More FDA Approves Breyanzi
FDA Approves Cabenuva and Vocabria
FDA Approves Cabenuva (cabotegravir and rilpivirine) Long-Acting Injectable HIV Treatment and Vocabria (cabotegravir) Oral HIV…
View More FDA Approves Cabenuva and Vocabria